Department of Psychology, Behavioral Neuroscience, State University of New York at Binghamton, Vestal, NY 13902, USA.
Brain Res. 2011 May 19;1391:132-46. doi: 10.1016/j.brainres.2011.03.048. Epub 2011 Apr 8.
Alcohol-induced Wernicke-Korsakoff syndrome (WKS) culminates in bilateral diencephalic lesion and severe amnesia. Using the pyrithiamine-induced thiamine deficiency (PTD) animal paradigm of WKS, our laboratory has demonstrated hippocampal dysfunction in the absence of gross anatomical pathology. Extensive literature has revealed reduced hippocampal neurogenesis following a neuropathological insult, which might contribute to hippocampus-based learning and memory impairments. Thus, the current investigation was conducted to determine whether PTD treatment altered hippocampal neurogenesis in a stage-dependent fashion. Male Sprague-Dawley rats were assigned to one of 4 stages of thiamine deficiency based on behavioral symptoms: pre-symptomatic stage, ataxic stage, early post-opisthotonus stage, or the late post-opisthotonus stage. The S-phase mitotic marker 5'-bromo-2'-deoxyuridine (BrdU) was administered at the conclusion of each stage following thiamine restoration and subjects were perfused 24 hours or 28 days after BrdU to assess cellular proliferation or neurogenesis and survival, respectively. Dorsal hippocampal sections were immunostained for BrdU (proliferating cell marker), NeuN (neurons), GFAP (astrocytes), Iba-1 (microglia), and O4 (oligodendrocytes). The PTD treatment increased progenitor cell proliferation and survival during the early post-opisthotonus stage. However, levels of neurogenesis were reduced during this stage as well as the late post-opisthotonus stage where there was also an increase in astrocytogenesis. The diminished numbers of newly generated neurons (BrdU/NeuN co-localization) was paralleled by increased BrdU cells that did not co-localize with any of the phenotypic markers during these later stages. These data demonstrate that long-term alterations in neurogenesis and gliogenesis might contribute to the observed hippocampal dysfunction in the PTD model and human WKS.
酒精性韦尼克-科尔萨科夫综合征(WKS)最终导致双侧间脑病变和严重的健忘症。使用吡哆醇诱导的硫胺素缺乏(PTD)WKS 动物模型,我们的实验室已经证明了海马功能障碍,而没有明显的解剖病理学。大量文献表明,神经病理学损伤后海马神经发生减少,这可能导致基于海马的学习和记忆障碍。因此,目前的研究旨在确定 PTD 治疗是否以阶段依赖的方式改变海马神经发生。雄性 Sprague-Dawley 大鼠根据行为症状分为 4 个阶段的硫胺素缺乏:前驱期、共济失调期、早期后角弓反张期或晚期后角弓反张期。在每个阶段的硫胺素恢复结束时,给予 S 期有丝分裂标记物 5'-溴-2'-脱氧尿苷(BrdU),并在 BrdU 后 24 小时或 28 天对受试者进行灌注,以分别评估细胞增殖或神经发生和存活。海马背侧切片用 BrdU(增殖细胞标志物)、NeuN(神经元)、GFAP(星形胶质细胞)、Iba-1(小胶质细胞)和 O4(少突胶质细胞)进行免疫染色。PTD 治疗增加了早期后角弓反张期的祖细胞增殖和存活。然而,神经发生水平在这个阶段以及晚期后角弓反张期也降低了,这个阶段星形胶质细胞生成增加。新生成的神经元(BrdU/NeuN 共定位)数量减少,与后期这些阶段中任何表型标志物都不共定位的 BrdU 细胞数量增加。这些数据表明,神经发生和神经胶质发生的长期改变可能导致 PTD 模型和人类 WKS 中观察到的海马功能障碍。